Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply

Malham, Mikkel; Jakobsen, Christian; Pærregaard, Anders; Hald, Mette; Virta, Lauri J.; Kolho, Kaija‐Leena; Wewer, Vibeke

doi:10.1111/apt.15733

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malham et al followed the patients for a median of 10 years and reported an alarming four‐time higher risk of suicide in pIBD patients compared to controls. Suicide in pIBD was most common among young adults, a few years after transition to adult care, 45 and is consistent with a tendency of suicide rates increasing with age 46 . On the other hand, Kyllönen et al found no increased risk of suicide in patients with JIA, however, patients were only 15 years old at end of follow‐up.…”

Section: Discussionsupporting

confidence: 59%

Psychiatric comorbidity in childhood onset immune‐mediated diseases—A systematic review and meta‐analysis

et al. 2022

Self Cite

View full text Add to dashboard Cite

Aim To estimate psychiatric comorbidity in childhood onset immune‐mediated inflammatory diseases (IMID). Methods The PRISMA guidelines were followed, and the protocol was registered at Prospero (ID: CRD42021233890). Literature was searched in PubMed, PsycINFO and Embase. Original papers on prevalence rates of diagnosed psychiatric disorders and/or suicide in paediatric onset inflammatory bowel disease (pIBD), rheumatic diseases (RD) and autoimmune liver diseases were selected. Pooled prevalence rates of psychiatric disorders (grouped according to ICD‐10 criteria) within the various IMID were calculated using random‐effects meta‐analysis. Risk of bias was evaluated by the Newcastle‐Ottawa scale. Results Twenty‐three studies were included; 13 describing psychiatric disorders in pIBD and 10 in RD. Anxiety and mood disorders were mostly investigated with pooled prevalence rates in pIBD of 6% (95% confidence interval (CI): 4%–9%) and 4% (95%CI: 2%–8%), respectively, in register‐based studies, and 33% (95%CI: 25%–41%) and 18% (95%CI: 12%–26%), respectively, in studies using psychiatric assessment. In RD, rates were 13% (95%CI: 12%–15%) for anxiety disorders and 20% (95%CI: 15%–26%) for mood disorders based on psychiatric assessment. Conclusion Anxiety and depression are commonly reported in childhood onset IMID. Physicians should be attentive to mental health problems in these patients as they seem overlooked.

show abstract